Johnson & Johnson (NYSE:JNJ)
| 172.19 Delayed Data As of Jul 28 |  -0.47 / -0.27%Today’s Change | 133.65 Today|||52-Week Range 173.65 | +9.41% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 172.66 |
| Today’s open | 172.79 |
| Day’s range | 172.00 - 173.38 |
| Volume | 5,750,714 |
| Average volume (3 months) | 7,036,637 |
| Market cap | $452.4B |
Data as of 4:19pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | -2.22% |
| Earnings growth (this year) | +20.62% |
| Earnings growth (next 5 years) | +6.09% |
| Revenue growth (last year) | +0.56% |
| P/E ratio | 30.4 |
| Price/Sales | 5.09 |
| Price/Book | 7.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.97 | +2.30% |
| LLYEli Lilly and Co | +2.91 | +1.19% |
| ABBVAbbVie | +0.57 | +0.48% |
| NVSNovartis | +0.58 | +0.63% |
Data as of 5:39pm ET, 07/28/2021
Financials
| Next reporting date | October 19, 2021 |
| EPS forecast (this quarter) | $2.36 |
| Annual revenue (last year) | $82.6B |
| Annual profit (last year) | $14.7B |
| Net profit margin | 17.82% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
